Evidence map›Paper›PMID 38720727›Full record

ArticleHeliyon2024

A framework for performance enhancement of classifiers in detection of prostate cancer from microarray gene.

Kalaiyarasi Mani, Harikumar Rajaguru

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kalaiyarasi ManiBannari Amman Institute of Technology, India.
Harikumar RajaguruBannari Amman Institute of Technology, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate cancer is a major world health problem for men. This shows how important early detection and accurate diagnosis are for better treatment and patient outcomes. This study compares different ways to find Prostate Cancer (PCa) and label tumors as normal or abnormal, with the goal of speeding up current work in microarray gene data analysis. The study looks at how well several feature extraction methods work with three feature selection strategies: Harmonic Search (HS), Firefly Algorithm (FA), and Elephant Herding Optimization (EHO). The techniques tested are Expectation Maximization (EM), Nonlinear Regression (NLR), K-means, Principal Component Analysis (PCA), and Discrete Cosine Transform (DCT). Eight classifiers are used for the task of classification. These are Random Forest, Decision Tree, Adaboost, XGBoost, and Support Vector Machine (SVM) with linear, polynomial, and radial basis function kernels. This study looks at how well these classifiers work with and without feature selection methods. It finds that the SVM with radial basis function kernel, using DCT for feature extraction and EHO for feature selection, does the best of all of them, with an accuracy of 94.8 % and an error rate of 5.15 %.

Indexed as

AdaboostElephant Herding OptimizationHarmonic searchMicroarray gene dataProstate cancer (PCa)Quadrature discriminant analysisXGboost

Identifiers

PMID38720727
PMCPMC11076651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.